⌘K
HDAX Therapeutics
Preclinical development • Pipeline advancement
HDAX Therapeutics is developing next-generation HDAC6 inhibitors to treat neurological and cardiometabolic diseases.
Preclinical development • Pipeline advancement
HDAX Therapeutics is developing next-generation HDAC6 inhibitors to treat neurological and cardiometabolic diseases.